To address the mechanism behind the selection process of IFNγR2-mutant tumor cells, we hypothesized that IFN-γ-insensitive tumor cells could escape the direct antitumor effects of IFN-γ, which would be preserved in tumor cells that have intact IFN-γ-signaling. The gene discussed is IFNG; the disease is neoplasm.